SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001493152-21-016074
Filing Date
2021-07-02
Accepted
2021-07-02 16:47:39
Documents
2

Document Format Files

Seq Description Document Type Size
1 form424b5.htm 424B5 464525
2 logo_1.jpg GRAPHIC 4014
  Complete submission text file 0001493152-21-016074.txt   471433
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

IRS No.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-256790 | Film No.: 211070921
SIC: 7389 Services-Business Services, NEC